] As of Mar. 20 02:10 P.M., Boryung Pharmaceutical slightly edged down 0.92% to 48,550 won (US$43.29). It had declined 10.59% through the past month. Standard deviation, which indicates variableness, records 1.9% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly volatility of Boryung Pharmaceutical was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -5.5%. Compared with its peer group. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.6, and thus the industrial comparison performance was not so good.
By HeRo (email@example.com
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.